Development Agreements in the Life Sciences Tools & Services Industry
19 Contracts & Agreements
- Adaptive Biotechnologies Corp (1 contract)
- ARQULE INC (2)
- Bio-Techne (1)
- ChromaDex Corp. (1)
- CODEXIS INC (1)
- EMMAUS LIFE SCIENCES, INC. (3)
- FLUIDIGM CORP (2)
- NEOGENOMICS INC (1)
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (3)
- PPD, Inc. (1)
- Quanterix Corp (2)
- Seer, Inc. (1)
- Amended and Restated Development and Commercialization Agreement by and between the Registrant and Invitae Corporation dated June 24, 2022 (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on August 8, 2022)
- Amendment to Development and Commercialization Agreement, dated as of June 3, 2021, by and between Pacific Biosciences of California, Inc. and Invitae Corporation (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on August 6, 2021)
- Development and Commercialization Agreement by and between the Registrant and Invitae Corporation dated January 12, 2021 (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on February 26, 2021)
- Assignment and Assumption Agreement, dated as of May 11, 2017, by and among Jaguar Holding Company I, Eagle Holding Company I, Pharmaceutical Product Development, LLC, and David... (PPD, Inc., Filed With SEC on February 26, 2021)
- Umbrella Development & Supply Agreement between the Registrant and Hamilton Company, dated March 9, 2020 (Seer, Inc., Filed With SEC on November 12, 2020)
- Development, Supply and Commercialization Agreement by and between Bio-Techne Corporation and Kantaro Biosciences, LLC dated May 18, 2020 (portions of which have been redacted as... (Bio-Techne, Filed With SEC on May 19, 2020)
- Letter Agreement, effective as of February 21, 2020, by and between Codexis, Inc. and GlaxoSmithKline Intellectual Property Development Limited (CODEXIS INC, Filed With SEC on May 8, 2020)
- Development Agreement, dated September 13, 2019, by and between NeoGenomics Laboratories, Inc. and Seagate Alico I, LLC (NEOGENOMICS INC, Filed With SEC on November 13, 2019)
- IVD Test Kit Development and Supply Agreement between Illumina, Inc. and Adaptive Biotechnologies Corporation, effective September 23, 2019 (Adaptive Biotechnologies Corp, Filed With SEC on November 12, 2019)
- First Amendment to STRATEC Development Services and Equity Participation Agreement and Second Amendment to Supply and Manufacturing Agreement, dated November 18, 2016, between the... (Quanterix Corp, Filed With SEC on November 9, 2017)
- STRATEC Development Services and Equity Participation Agreement, dated August 15, 2011, between the Registrant and STRATEC Biomedical Systems AG (Quanterix Corp, Filed With SEC on November 9, 2017)
- Joint Development Agreement Between The Procter & Gamble Company and CHROMADEX, INC. (ChromaDex Corp., Filed With SEC on March 17, 2016)
- ADDENDUM TO JOINT RESEARCH AND DEVELOPMENT AGREEMENT (the Agreement) By and Between CELLSEED INC. (CELLSEED) And EMMAUS MEDICAL INC. (EMMAUS) (EMMAUS LIFE SCIENCES, INC., Filed With SEC on May 8, 2014)
- ADDENDUM TO JOINT RESEARCH AND DEVELOPMENT AGREEMENT (the Agreement) By and Between CELLSEED INC. (CELLSEED) And EMMAUS MEDICAL INC. (EMMAUS) (EMMAUS LIFE SCIENCES, INC., Filed With SEC on October 6, 2011)
- Joint Research and Development Agreement (EMMAUS LIFE SCIENCES, INC., Filed With SEC on May 4, 2011)
- QUALITYAGREEMENT FOR DEVELOPMENT OF IN-VITRO DIAGNOSTICS DEVICES Between Novartis Vaccines and Diagnostics, Inc. 4560 Horton Street, Emeryville, CA 94608 subsequently referred to... (FLUIDIGM CORP, Filed With SEC on February 2, 2011)
- QUALITYAGREEMENT FOR DEVELOPMENT OF IN-VITRO DIAGNOSTICS DEVICES Between Novartis Vaccines and Diagnostics, Inc. 4560 Horton Street, Emeryville, CA 94608 subsequently referred to... (FLUIDIGM CORP, Filed With SEC on January 18, 2011)
- Ex-10.9 Amended and Restated Research and Development Agreement (ARQULE INC, Filed With SEC on March 16, 2005)
- Ex-10.1 Amended and Restated Reseach, Development (ARQULE INC, Filed With SEC on May 14, 2001)
